Oncosil Medical Ltd has released a press release.
Positive Preliminary Results from PANCOSIL Phase 1-2 Study
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from OncoSil Medical
- Appendix 4E and Annual Report
- Completion of Recruitment in TRIPP-FFX Clinical Trial
- Completion of Recruitment in PANCOSIL Study
- OSL announces $8.7m capital raise to drive commercialisation
- Consolidation/Split - OSL
Later from OncoSil Medical
- Response to ASX Aware Letter
- OSPREY Analysis Shows Survival Benefit for OncoSil Patients
- OncoSil receives $1.84m R&D tax incentive
- Trading Halt
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical